Regulus Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
12.75
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.49
|
-0.50
|
-0.01
|
-2.04%
|
|
2022-06-30
|
-0.48
|
-0.50
|
-0.02
|
-4.17%
|
|
2022-03-31
|
-0.53
|
-0.50
|
0.03
|
5.66%
|
|
2021-12-31
|
-0.67
|
-0.70
|
-0.03
|
-4.48%
|
|
2021-09-30
|
-0.77
|
-1.00
|
-0.23
|
-29.87%
|
|
2021-06-30
|
-0.80
|
-0.80
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.90
|
-0.80
|
0.10
|
11.11%
|
|
2020-12-31
|
-1.40
|
-0.30
|
1.10
|
78.57%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.50
|
|
2021-12-31
|
-3.30
|
|
2020-12-31
|
-3.25
|
|
2019-12-31
|
-1.10
|
|
2018-12-31
|
-5.52
|
|
2017-12-31
|
-13.32
|
|
2016-12-31
|
-9.80
|
|
2015-12-31
|
-1.09
|
|
2014-12-31
|
-7.78
|
|
2013-12-31
|
-6.72
|
|
2012-12-31
|
-2.76
|